Product Images Chateal Eq

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Chateal Eq NDC 50102-230 by Afaxys Pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

CIRCULATORY DISEASE MORTALITY RATES PER 100,000 WOMAN YEARS BY AGE, SMOKING STATUS AND ORAL CONTRACEPTIVE USE - levo ethi fig1

CIRCULATORY DISEASE MORTALITY RATES PER 100,000 WOMAN YEARS BY AGE, SMOKING STATUS AND ORAL CONTRACEPTIVE USE - levo ethi fig1

This text appears to be a table showing various categories and ranges for pregnancy and blood clots among women who are not pregnant, not using COC (a type of birth control pill), or postpartum (up to 12 weeks after giving birth). The table provides information on the number of women with a blood clot out of 10,000 women years (WY) in each category, but the specific data is not entirely clear due to formatting and missing values. Additionally, there is a note regarding pregnancy data that is based on actual duration of pregnancy for reference studies.*

Figure-2 - levo ethi fig2

Figure-2 - levo ethi fig2

This text provides information about the results of different studies on the association between using Combined Oral Contraceptives (COC) and different health outcomes. The studies present the Odds Ratio (OR), Relative Risk (RR) or Hazard Ratio (HR) and the confidence intervals for different comparisons, such as Ever COC vs. Never COC use or Current COC use vs. Never-use. The studies evaluate the association with outcomes such as women's health, sex hormones, and other medical conditions.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg (28 Tablets Pouch) - levo ethi fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg (28 Tablets Pouch) - levo ethi fig3

This appears to be a chart comparing various methods of birth control and their effectiveness at preventing pregnancy. The chart shows the number of pregnancies per 100 women that can be expected in one year when using different forms of birth control, ranging from fewer than 1 pregnancy per 100 women for the most effective methods such as implants and sterilization, up to 85 or more pregnancies per 100 women for no birth control at all. Different methods of birth control are listed, including hormonal methods (pills, patches, injections, vaginal rings), barrier methods (condoms, diaphragms), fertility awareness methods (avoiding sex during fertile days), and withdrawal.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg (84 Tablets Carton) - levo ethi fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.15 mg/0.03 mg (84 Tablets Carton) - levo ethi fig4

This text is a label for a product that encourages the user to store it under controlled temperature. The product name is Orange, and there is a mention of a Green color and a Figure A, which may be related to the product. Additionally, there is a table with the days of the week and a line with illegible characters. Overall, the text provides limited information and context.*

levo ethi fig5

levo ethi fig5

levo ethi fig6

levo ethi fig6

levo ethi str1

levo ethi str1

The text is not useful since it only provides chemical formula and molecular weight of Levonorgestrel.*

levo ethi str2

levo ethi str2

Description not-available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.